DMT

ADVERTISEMENT

Identification

Molecular formula
C13H18N4
CAS Number
61-50-7
IUPAC Name
N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine
Molecular Weight
188.27g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.1240g/cm3
Synonyms
rizatriptan
Interesting facts

Interesting Facts about N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine

N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine, commonly referred to in research circles for its unique structure and potential applications, is an intriguing compound in the field of medicinal chemistry.

Key Features

  • Pharmaceutical Potential: This compound belongs to a class of drugs that are primarily explored for their potential in treating various diseases, including cancer and fungal infections. The presence of triazole and indole moieties in its structure can contribute to its biological activity.
  • Triazole Component: The triazole ring is known for its role in many pharmacologically active compounds. It has been often utilized in the synthesis of antifungal agents due to its unique nitrogen-containing structure.
  • Indole Derivative: The indole structure is prevalent in many natural products and has been reputed for its diverse pharmacological properties, such as anti-inflammatory and antitumor activities.
  • Dimethylamine Group: The N,N-dimethyl functionality increases lipophilicity, which can enhance the passage of the compound across cellular membranes, potentially leading to improved bioavailability.

Research Insights

Emerging studies suggest that compounds like N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine can target specific pathways in disease mechanisms. These pathways often involve:

  • Cell proliferation
  • Apooptosis modulation
  • Antimicrobial action

Current research continues to explore the compound's full potential, with implications stretching beyond just anticancer and antifungal properties. As chemical scientists dive deeper into its mechanisms, its utilization may expand to address both acute and chronic health conditions.

In conclusion, the study of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine reflects the teeny intricate connection between structure and biological activity in medicinal chemistry. Truly, as Marie Curie would say, "One never notices what has been done; one can only see what remains to be done."

ADVERTISEMENT